Safe Implementation of Thrombolysis in Stroke - Monitoring Study


Phase N/A Results N/A

Trial Description

Study to evaluate the safety and efficacy of intravenous alteplase within 3 hours of symptom onset in acute ischemic stroke patients



  • Alteplase Drug
    ARM 1: Kind: Experimental
    Label: thrombolytic therapy in stroke

Trial Design

  • Observation: Cohort
  • Perspective: Retrospective
  • Sampling: Non-Probability Sample

Trial Population

acute stroke patients in the European Union


Type Measure Time Frame Safety Issue
Primary Occurrence of symptomatic intracerebral hemorrhage (SICH) up to 36 hours No
Primary Mortality rate 3 months No
Secondary Independence for activities of daily living 3 months No